Prognostic value of soluble urokinase‐type plasminogen activator receptor in coronary artery disease: A meta‐analysis

BACKGROUND: A potential inflammatory biomarker, soluble urokinase‐type plasminogen activator receptor (suPAR) has been utilized to assist the prognostic assessment of coronary artery disease (CAD) patients; however, outcomes have been inconsistent. The prognostic relevance of suPAR as a predictor of...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yang, Ding, Yaqun, Zhao, Yinjie, Gui, Yongqing, Shen, Yajing, Xiang, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787755/
https://www.ncbi.nlm.nih.gov/pubmed/36039688
http://dx.doi.org/10.1111/eci.13867

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787755/
https://www.ncbi.nlm.nih.gov/pubmed/36039688
http://dx.doi.org/10.1111/eci.13867

Ejemplares similares